Skip to main content

Takeda to buy Ariad Pharma for $4.7 billion

Takeda to acquire all shares of once-battered maker of leukemia treatment Iclusig.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.